Yong-Zhong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yong-Zhong Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
C‐X Yang
Changzhou Traditional Chinese Medical Hospital, Changzhou, Jiangsu Province, China
1 shared publicationD Wei
Changzhou Traditional Chinese Medical Hospital, Changzhou, Jiangsu Province, China
1 shared publicationG Chen
Changzhou Traditional Chinese Medical Hospital, Changzhou, Jiangsu Province, China
1 shared publication- Libo Luo
Changzhou No. 7 People's Hospital, China
1 shared publication - Ning Xu
Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lunds University, S-221 85 Lund, Sweden
1 shared publication - Xiangke Pu
Third People's Hospital of Changzhou, Jiangsu 213001, China
1 shared publication
Latest Publications
- 5 March 2010
- Published by Wiley in Australian Dental Journal
- Vol. 55 (1) , 70-78
Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy
Background: Recent data have demonstrated increased lipid peroxidation (LPO) levels and oxidative stress in periodontitis. Malondialdehyde (MDA) and superoxide dismutase (SOD) are both increased during oxidative stress. Furthermore, this study examined SOD concentration, total oxidative status (TOS) and MDA levels in periodontal patients and investigated the longitudinal effect of periodontal therapy on the index levels of chronic periodontitis (CP) patients.Methods: Serum, saliva and gingival crevicular fluid (GCF) samples were obtained from 48 CP patients and 35 healthy control subjects prior to, as well as after 16 weeks following non‐surgical post‐periodontal therapy. MDA, TOS and SOD and clinical parameters were determined pre‐ and post‐therapy.Results: The levels of TOS and SOD values were significantly higher in the CP group than in the control group (p < 0.05), but only MDA in GCF. Post‐periodontal therapy, serum, saliva and GCF TOS and SOD levels significantly decreased compared to basal levels (p < 0.05), but only MDA in GCF.Conclusions: LPO was higher in the periodontal region, with TOS and SOD increasing both locally and peripherally. Non‐surgical therapy can restore and control the subject antioxidant capacity by locally and systemically modifying the levels of MDA, TOS and SOD.
- 5 March 2010
- Published by Wiley in Australian Dental Journal
- Vol. 55 (1) , 70-78
Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy
Background: Recent data have demonstrated increased lipid peroxidation (LPO) levels and oxidative stress in periodontitis. Malondialdehyde (MDA) and superoxide dismutase (SOD) are both increased during oxidative stress. Furthermore, this study examined SOD concentration, total oxidative status (TOS) and MDA levels in periodontal patients and investigated the longitudinal effect of periodontal therapy on the index levels of chronic periodontitis (CP) patients.Methods: Serum, saliva and gingival crevicular fluid (GCF) samples were obtained from 48 CP patients and 35 healthy control subjects prior to, as well as after 16 weeks following non‐surgical post‐periodontal therapy. MDA, TOS and SOD and clinical parameters were determined pre‐ and post‐therapy.Results: The levels of TOS and SOD values were significantly higher in the CP group than in the control group (p < 0.05), but only MDA in GCF. Post‐periodontal therapy, serum, saliva and GCF TOS and SOD levels significantly decreased compared to basal levels (p < 0.05), but only MDA in GCF.Conclusions: LPO was higher in the periodontal region, with TOS and SOD increasing both locally and peripherally. Non‐surgical therapy can restore and control the subject antioxidant capacity by locally and systemically modifying the levels of MDA, TOS and SOD.
- Open Access
- 23 January 2010
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 9 (1) , 5
Impaired plasma lipid profiles in acute hepatitis
The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis.
- 23 January 2010
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 9 (1) , 5
Open AccessImpaired plasma lipid profiles in acute hepatitis
The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis.
- Open Access
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (31) , 4260-4263
Oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus
AIM: To compare the oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus in Chinese patients with chronic hepatitis B.
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (31) , 4260-4263
Open AccessOligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus
AIM: To compare the oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus in Chinese patients with chronic hepatitis B.